Curaleaf Holdings (CURLF) Change in Receivables (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Change in Receivables of $17.0 million for Q4 2024, up 142.72% year-over-year from $7.0 million in Q1 2024, and up 793.89% quarter-over-quarter from $1.9 million in Q3 2024.
Curaleaf Holdings (CURLF) Change in Receivables (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Change in Receivables history runs 6 years deep, the most recent figure standing at $17.0 million for Q4 2024.
- In Q4 2024, Change in Receivables rose 142.72% year-over-year to $17.0 million; the TTM figure through Dec 2024 stood at $35.6 million (up 51.38% YoY), while the FY2025 annual figure was $11.0 million, up 40.69% from the prior year.
- Change in Receivables for Q4 2024 stood at $17.0 million, up from $1.9 million in the prior quarter.
- The five-year high for Change in Receivables was $17.0 million in Q4 2024, with the low at -$23.0 million in Q4 2021.
- The 5-year median for Change in Receivables is $2.4 million (2020), against an average of $1.2 million.
- Peak annual rise in Change in Receivables reached 6133.1% in 2021, while the deepest fall reached 748.38% in 2021.
- Curaleaf Holdings' Change in Receivables stood at -$2.7 million in 2020, then tumbled by 748.38% to -$23.0 million in 2021, then jumped by 114.99% to $3.4 million in 2022, then soared by 102.96% to $7.0 million in 2023, then surged by 142.72% to $17.0 million in 2024.
- Business Quant data shows CURLF's Change in Receivables at $17.0 million in Q4 2024, $1.9 million in Q3 2024, and $7.0 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Curaleaf Holdings | 2.51 Bn | 2.42 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 16.97 Mn |
| Dec 31, 2024 | 16.97 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Dec 31, 2023 | 6.99 Mn |
| Dec 31, 2023 | 6.99 Mn |
| Sep 30, 2023 | 9.76 Mn |
| Sep 30, 2023 | 9.76 Mn |
| Dec 31, 2022 | 3.44 Mn |
| Dec 31, 2022 | 3.44 Mn |
| Sep 30, 2022 | 3.33 Mn |
| Sep 30, 2022 | 3.33 Mn |
| Jun 30, 2022 | -3.76 Mn |
| Jun 30, 2022 | -3.76 Mn |
| Mar 31, 2022 | 318,000.00 |
| Mar 31, 2022 | 318,000.00 |
| Dec 31, 2021 | -22.97 Mn |
| Dec 31, 2021 | -22.97 Mn |
| Sep 30, 2021 | 8.85 Mn |
| Sep 30, 2021 | 8.85 Mn |